These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9606458)

  • 1. ASHP policy-development process: opportunities for improvement. ASHP Ad Hoc Committee on Policy Development.
    Am J Health Syst Pharm; 1998 May; 55(10):1044-9. PubMed ID: 9606458
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of the ASHP Ad Hoc Committee on Ethnic Diversity and Cultural Competence.
    ASHP Ad Hoc Committee on Ethnic Diversity and Cultural Competence
    Am J Health Syst Pharm; 2005 Sep; 62(18):1924-30. PubMed ID: 16141112
    [No Abstract]   [Full Text] [Related]  

  • 3. Report of the ASHP Task Force on Organizational Structure.
    ASHP Task Force on Organizational Structure
    Am J Health Syst Pharm; 2014 Jun; 71(12):1049-54. PubMed ID: 24865763
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP professional policy recommendations--invitation to comment.
    Am J Health Syst Pharm; 2005 Apr; 62(7):748-52. PubMed ID: 15790804
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP professional policy recommendations-Invitation to comment.
    Am J Health Syst Pharm; 2017 Apr; 74(8):e121-e125. PubMed ID: 28389460
    [No Abstract]   [Full Text] [Related]  

  • 6. ASHP professional policy recommendations--invitation to comment.
    Am J Health Syst Pharm; 2015 Apr; 72(8):e37-42. PubMed ID: 25825192
    [No Abstract]   [Full Text] [Related]  

  • 7. Professional Policies Approved by the 2019 ASHP House of Delegates.
    Am J Health Syst Pharm; 2019 Sep; 76(18):1442-1445. PubMed ID: 31375820
    [No Abstract]   [Full Text] [Related]  

  • 8. Health care reform law offers opportunities for pharmacists.
    Batshon L
    Consult Pharm; 2010 Jun; 25(6):388. PubMed ID: 20534410
    [No Abstract]   [Full Text] [Related]  

  • 9. Getting involved in professional policy development.
    Allcock NM
    Am J Health Syst Pharm; 2007 Jun; 64(11):1144, 1146. PubMed ID: 17519453
    [No Abstract]   [Full Text] [Related]  

  • 10. Professional policy as a catalyst to pharmacy's transformation.
    Zellmer WA
    Am J Health Syst Pharm; 2011 Dec; 68(23):2261-4. PubMed ID: 22095815
    [No Abstract]   [Full Text] [Related]  

  • 11. ASHP guidelines on pharmaceutical services in correctional facilities. American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 1995 Aug; 52(16):1810-3. PubMed ID: 8528841
    [No Abstract]   [Full Text] [Related]  

  • 12. ASHP statement on the use of medications for unlabeled uses.
    Am J Hosp Pharm; 1992 Aug; 49(8):2006-8. PubMed ID: 1442846
    [No Abstract]   [Full Text] [Related]  

  • 13. The 2016 Elections, ASCP's Policy Agenda, and Grassroots Activity.
    Rankin P; Baldwin P
    Consult Pharm; 2016 Feb; 31(2):120. PubMed ID: 26842690
    [No Abstract]   [Full Text] [Related]  

  • 14. ASHP guidelines for the use of investigational drugs in organized health-care settings.
    Am J Hosp Pharm; 1991 Feb; 48(2):315-9. PubMed ID: 2003508
    [No Abstract]   [Full Text] [Related]  

  • 15. ASHP daily briefing.
    Thompson CA
    Am J Health Syst Pharm; 2011 Sep; 68(18):1696-7. PubMed ID: 21880883
    [No Abstract]   [Full Text] [Related]  

  • 16. Professional policies approved by the 2020 ASHP March virtual House of Delegates.
    Am J Health Syst Pharm; 2020 Jun; 77(13):1078-1080. PubMed ID: 32383729
    [No Abstract]   [Full Text] [Related]  

  • 17. ASHP guidelines on the pharmacist's role in home care. Developed through the ASHP Council on Professional Affairs with the assistance of the Executive Committee and Professional Practice Committee of the ASHP Section of Home Care Practitioners and approved by the ASHP Board of Directors on April 27, 2000.
    Am J Health Syst Pharm; 2000 Jul; 57(13):1252-7. PubMed ID: 10902068
    [No Abstract]   [Full Text] [Related]  

  • 18. The ostrich syndrome in American pharmacy.
    Whitney HA
    Ann Pharmacother; 2006 Jan; 40(1):115. PubMed ID: 16397304
    [No Abstract]   [Full Text] [Related]  

  • 19. Professional policies approved by the 2010 ASHP House of Delegates.
    Am J Health Syst Pharm; 2010 Aug; 67(16):e50-4. PubMed ID: 20689110
    [No Abstract]   [Full Text] [Related]  

  • 20. Professional Policies Approved by the 2016 ASHP Virtual House of Delegates.
    Am J Health Syst Pharm; 2017 Feb; 74(4):e95. PubMed ID: 28179251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.